2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
135
Carcinoma, Hepatocellular
81
Neoplasms
53
Small Cell Lung Carcinoma
51
Breast Neoplasms
50
Lung Neoplasms
45
Triple Negative Breast Neoplasms
41
Colorectal Neoplasms
39
Melanoma
38
Carcinoma, Transitional Cell
37
Urinary Bladder Neoplasms
33
Neoplasm Metastasis
32
Carcinoma, Renal Cell
30
Ovarian Neoplasms
20
Uterine Cervical Neoplasms
19
Stomach Neoplasms
17
Squamous Cell Carcinoma of Head and Neck
17
Head and Neck Neoplasms
15
Liver Neoplasms
14
Prostatic Neoplasms
13
Glioblastoma
12
Solid Tumors
11
Recurrence
11
Sarcoma
10
Esophageal Neoplasms
10
Pancreatic Neoplasms
9
Lymphoma
9
Kidney Neoplasms
9
Endometrial Neoplasms
9
Mesothelioma, Malignant
8
Interventions
Paclitaxel
11
Carboplatin
8
Radiotherapy
7
Letrozole
7
Cyclophosphamide
7
Trastuzumab
5
Chemotherapy, Adjuvant
5
Doxorubicin
4
Brachytherapy
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
atamestane
3
Toremifene
3
Tamoxifen
3
Radiotherapy, Conformal
3
Magnetic Resonance Spectroscopy
3
Epirubicin
3
Docetaxel
3
Cryosurgery
3
Cisplatin
3
pertuzumab
2
Surgical Procedures, Operative
2
Radiation
2
Lapatinib
2
Fulvestrant
2
Estrogen Receptor Modulators
2
Cryotherapy
2
Capecitabine
2
Biopsy
2
Aromatase Inhibitors
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Ductal, Breast
×
atezolizumab
×
Clear all
NCT02620280
2024-03-06
NeoTRIPaPDL1
Fondazione Michelangelo
Phase 3
Completed
278 enrolled